Cyclerion Therapeutics, Inc. Common Stock
Symbol: CYCN (NASDAQ)
2.11
▲ (1.44%) 0.030
Company Description:
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Key Stats
- Today's Open: $2.04
- Today's High: $2.184
- Today's Low: $2.045
- Today's Volume: 33.35K
- Yesterday Close: $2.08
- Yesterday High: $2.1596
- Yesterday Low: $2.06
- Yesterday Volume: 61.03K
- Last Min Volume: 7
- Last Min High: $2.11
- Last Min Low: $2.11
- Last Min VWAP: $2.11
Company Profile
- Name: Cyclerion Therapeutics, Inc. Common Stock
- Website: https://www.cyclerion.com
- Listed Date: 2019-03-18
- Location: CAMBRIDGE, MA
- Market Status: Active
- CIK Number: 0001755237
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $6.92M
- Round Lot: 100
- Outstanding Shares: 3.20M
- Asset Type: CS
RECENT FILINGS FOR CYCN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-17 | SCHEDULE 13G | View |
| 2025-09-23 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-11 | 4 | View |
| 2025-08-05 | 10-Q | View |
| 2025-06-18 | 8-K | View |
| 2025-05-15 | EFFECT | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-13 | CORRESP | View |
| 2025-05-12 | UPLOAD | View |
| 2025-05-07 | 8-K | View |
| 2025-05-07 | 424B5 | View |
| 2025-05-06 | S-3 | View |
| 2025-05-06 | 10-Q | View |
| 2025-04-29 | DEFA14A | View |
| 2025-04-29 | DEF 14A | View |
| 2025-03-28 | SCHEDULE 13D/A | View |
| 2025-03-27 | 4 | View |
| 2025-03-27 | 4 | View |
| 2025-03-25 | 8-K | View |
Latest News on CYCN